Acurx Pharmaceuticals Inc.

ACXP | NASDAQ

Price Alert Chart Builder DCF Calculator

$1.33

-$0.06 (-4.32%)

At close: Sep 21, 2026, 4:00 PM ET

$1.35

+$0.02 (+1.50%)

Pre-market: Sep 22, 2026, 8:10 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

TTM Period Ending	Q2 2026 Jun 29, 2026	Q1 2026 Mar 30, 2026	Q4 2025 Dec 30, 2025	Q3 2025 Sep 29, 2025	Q2 2025 Jun 29, 2025	Q1 2025 Mar 30, 2025	Q4 2024 Dec 30, 2024	Q3 2024 Sep 29, 2024	Q2 2024 Jun 29, 2024	Q1 2024 Mar 30, 2024	Q4 2023 Dec 30, 2023	Q3 2023 Sep 29, 2023	Q2 2023 Jun 29, 2023	Q1 2023 Mar 30, 2023	Q4 2022 Dec 30, 2022	Q3 2022 Sep 29, 2022	Q2 2022 Jun 29, 2022	Q1 2022 Mar 30, 2022	Q4 2021 Dec 30, 2021	Q3 2021 Sep 29, 2021	Q2 2021 Jun 29, 2021	Q1 2021 Mar 30, 2021
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Income	-7.67M	-7.63M	-8.06M	-9.23M	-10.02M	-11.88M	-14.1M	-16.44M	-16.73M	-16.05M	-14.58M	-12.72M	-13.15M	-12.33M	-12.09M	-11.46M	-12.56M	-14.01M	-12.81M	-11.28M	-7.95M	-4.8M
Interest Income	162.81K	133.16K	98.16K	59.32K	23.4K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	-7.51M	-7.5M	-7.97M	-9.17M	-10M	-11.87M	-14.1M	-16.44M	-16.73M	-16.05M	-14.58M	-12.72M	-13.15M	-12.33M	-12.09M	-11.46M	-12.56M	-13.94M	-12.75M	-11.21M	-7.89M	-4.8M
Net Income	-7.51M	-7.5M	-7.97M	-9.17M	-10M	-11.87M	-14.1M	-16.44M	-16.73M	-16.05M	-14.58M	-12.72M	-13.15M	-12.33M	-12.09M	-11.46M	-12.56M	-13.94M	-12.75M	-11.21M	-7.89M	-4.8M
Selling & General & Admin	7.63B	7.63B	6.26B	6.85M	6.88M	7.43M	8.7M	9.92M	10.06M	9.47M	8.53M	7.19M	7.37M	7.37M	7.34M	7.42M	8.99M	11.25M	10.78M	9.51M	6.65M	3.19M
Research & Development	1.83B	1.83B	1.83B	2.38M	3.15M	4.45M	5.4M	6.52M	6.67M	6.58M	6.04M	5.53M	5.78M	4.95M	4.75M	4.04M	3.57M	2.76M	2.03M	1.77M	1.3M	1.61M
Other Expenses	-9.46B	-9.46B	-8.08B	0	0	0	n/a	0	0	0	0	0	n/a	n/a	n/a	0	n/a	0	0	n/a	n/a	n/a
Operating Expenses	7.67M	7.63M	8.06M	9.23M	10.02M	11.88M	14.1M	16.44M	16.73M	16.05M	14.58M	12.72M	13.15M	12.33M	12.09M	11.46M	12.56M	14.01M	12.81M	11.28M	7.95M	4.8M
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	-1.6M	-1.6M	-1.6M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	716.68K	716.68K	716.68K	716.68K	3.35M	3.35M	3.35M	3.35M	n/a
Cost & Expenses	7.67M	7.63M	8.06M	9.23M	10.02M	11.88M	14.1M	16.44M	16.73M	16.05M	14.58M	12.72M	13.15M	12.33M	12.09M	11.46M	12.56M	14.01M	12.81M	11.28M	7.95M	4.8M
Income Tax Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Shares Outstanding (Basic)	4.26M	1.5M	1.5M	1.63M	1.19M	1M	851.55K	818.15K	791.25K	773.65K	673.1K	650.25K	609.3K	581.95K	580.3K	557.4K	513.15K	511.65K	511.23K	505.8K	348.4K	477.05K
Shares Outstanding (Diluted)	4.26M	1.5M	1.5M	1.63M	1.19M	1M	851.55K	818.15K	791.25K	773.65K	673.1K	650.25K	609.3K	581.95K	580.3K	557.4K	513.15K	511.65K	511.23K	505.8K	348.4K	477.05K
EPS (Basic)	-3.55	-4.91	-5.93	-8.53	-10.75	-14.07	-17.59	-21.92	-23.26	-23.65	-22.99	-21.01	-22.62	-22.22	-22.42	-22	-24.80	-31	-28.80	-25.80	-19.40	-9.91
EPS (Diluted)	-3.55	-4.91	-5.93	-8.53	-10.75	-14.07	-17.59	-21.92	-23.26	-23.65	-22.99	-21.01	-22.62	-22.22	-22.42	-24.40	-27.20	-33.40	-31.20	-25.80	-19.40	-9.91
EBITDA	-7.56M	-7.5M	-5.82M	-4.24M	-2.25M	-4.12M	-8.5M	-8.5M	-8.5M	-4.38M	-2.9M	-2.9M	-2.9M	-2.9M	-2.67M	-2.67M	-2.67M	-2.6M	66.5K	-1.03M	-2.34M	-2.41M
EBIT	-7.56M	-7.5M	-7.97M	-9.17M	-10M	-11.87M	-14.1M	-16.44M	-16.73M	-16.05M	-14.58M	-12.72M	-13.15M	-12.33M	-12.09M	-11.46M	-12.56M	-13.94M	-12.75M	-11.21M	-7.89M	-4.8M
Depreciation & Amortization	n/a	n/a	2.15M	4.93M	7.75M	7.75M	5.6M	7.94M	8.23M	11.67M	11.67M	9.82M	10.25M	9.42M	9.42M	8.79M	9.89M	11.34M	12.81M	10.19M	5.54M	2.39M